Our commitment to quality: batch by batch
Avextra offers high-quality cannabis-based medicines. Our strength lies within our cultivation in Portugal and the combination of traditional and high-tech extraction methods in Germany. Discover more insights from our CMO David Reckeweg-Lecompte by watching this video.
A selection of other videos
Compiled from the various subject areas.
We at Avextra have had an exciting and successful year! In 2024, we achieved many important milestones. As we look ahead to the next chapter of our journey in 2025, here is look back at some of our key highlights from 2024.
Reflecting on a remarkable and successful year at Avextra. We’re ready for another year of achievements in 2024.
Avextra combines decades of experience in plant-based pharmaceutical production with innovative manufacturing processes. Our experts harness the therapeutic potential of the cannabis plant to improve patients' quality of life.
Avextra offers high-quality cannabis-based medicines. Our strength lies within our cultivation in Portugal and the combination of traditional and high-tech extraction methods in Germany. Discover more insights from our CMO David Reckeweg-Lecompte by watching this video.
At Avextra, we focus on research and development of cannabis medicine to create innovative dosage forms and drive evidence-based research. Learn more with this video.
Hear from Avextra’s experts how we are setting new standards in cannabis medicine and realizing the full potential of the plant in this video clip.
Check out our state-of-the-art medical cannabis cultivation facility in Portugal in this behind-the-scenes tour!
Our 2022 highlight video gives a sneak peek at some of the exciting things we've been working on and hints at what's to come.
Europe’s leader in Cannabis-based medicine
Das komplette Interview zu möglichen Vorteilen der Therapie mit medizinischem Cannabis finden Sie im Media Center für Fachkreise.
Das komplette Interview über den Einsatz von Cannabis-Medizin in der Palliativmedizin finden Sie im Media Center für Fachkreise.
Das komplette Interview zum möglichen Einsatz von Cannabis-Medizin in der Kinderpalliativversorgung finden Sie im Media Center für Fachkreise.
Podcasts

Neil Smith featured on Planted with Sara Payan.
Sara discusses the European cannabis landscape and new movement in R&D with Neil Smith, COO of German bio-pharmaceutical company Avextra.
Press Releases
Please find the latest press releases from Avextra here.
Avextra und SynQube GmbH geben strategische Partnerschaft in der Arzneimittelentwicklung bekannt
Avextra und SynQube geben ihre strategische Partnerschaft bekannt. Beide Partner bündeln ihre umfangreiche Expertise im Bereich der Cannabistherapie für eine verbesserte Patientenversorgung in der GKV-Erstattung.
Avextra AG Announces Closing of Follow-On Capital Raise Supported by Existing and New Institutional Investors
BENSHEIM, Germany, Feb. 07, 2024 (GLOBE NEWSWIRE) — Avextra AG (“Avextra” or the “Company”), a leading European vertically-integrated manufacturer and developer of pharmaceutical cannabis-based medicines…
Mit der OCEAN Studie gemeinsam für mehr Evidenz in der Cannabis-Therapie
Bensheim, 23.01.2024 – Erste Studien zeigen, dass neuropathische Schmerzformen, wie CINP, eine vielversprechende Indikation für den Nutzen von CBMs darstellen könnten. Jedoch fehlt – wie…
Avextras stellt seine Allianz für evidenzbasierte Cannabis-Medizin vor und kündigt seine Unterstützung für BELCANTO an.
Bensheim, 18.10.2023 – Zum Deutschen Schmerzkongress in Mannheim kündigt Avextra seine Allianz für Evidenz mit dem Start von BELCANTO an: der ersten von Avextra unterstützten…
Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria
Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich from September 14 to 17, 2022…
Avextra und die Deutsche Gesellschaft für Schmerzmedizin – mit der OCEAN Studie gemeinsam für mehr Evidenz in der Cannabis-Therapie
Marla Luther is the new Chief Strategy Officer at Eurox Pharma, the leading European vertically-integrated manufacturer of cannabis-based medicines, which will operate under the Avextra…
Avextra Continues its European Expansion, Successfully Exporting Medical Cannabis Extracts to Italy
Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich from September 14 to 17, 2022…
Deutschland legt Plan zur begrenzten Legalisierung von Cannabis für den Freizeitgebrauch in abgestufter Form vor.
Marla Luther is the new Chief Strategy Officer at Eurox Pharma, the leading European vertically-integrated manufacturer of cannabis-based medicines, which will operate under the Avextra…
Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development
Avextra and SynQube jointly announce their strategic partnership. Both partners are combining their extensive expertise in the field of cannabinoid therapy to improve patient care…
Avextra AG Announces Closing of Follow-On Capital Raise Supported by Existing and New Institutional Investors
BENSHEIM, Germany, Feb. 07, 2024 (GLOBE NEWSWIRE) — Avextra AG (“Avextra” or the “Company”), a leading European vertically-integrated manufacturer and developer of pharmaceutical cannabis-based medicines…
German Pain Association (DGS) and pharmaceutical company Avextra join forces to launch their new study OCEAN
Bensheim, Germany, January 23, 2024 – Avextra AG (“Avextra” or the “Company”), a leading European vertically-integrated manufacturer and developer of pharmaceutical cannabis-based medicines (CBMs) located…
AVEXTRA invests up to 15 million euros in the development of new medical cannabis research in partnership with IUCS-CESPU
Lisbon, January 17th, 2024 – Avextra, the leading German manufacturer of cannabis-based medicines, has entered a strategic, long-term partnership with the Instituto Universitário de Ciências…
Avextra Unveils its Alliance for Evidence and Announces its Support of BELCANTO: A Clinical Trial for Oncology Patients
Bensheim, 18.10.2023 – Avextra is launching its Alliance for Evidence-based Cannabis Medicine: a platform focused on collaborating with healthcare professionals and researchers to generate real-world…
Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria
Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich from September 14 to 17, 2022…
Avextra Continues its European Expansion, Successfully Exporting Medical Cannabis Extracts to Italy
Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich from September 14 to 17, 2022…
Germany unveils scaled-down recreational cannabis legalization plan
Marla Luther is the new Chief Strategy Officer at Eurox Pharma, the leading European vertically-integrated manufacturer of cannabis-based medicines, which will operate under the Avextra…
PRESS CONTaCT
